Lv1
100 积分 2022-03-27 加入
Identification of a novel RSRC1-ALK (R6: A20) fusion using next-generation sequencing technique
7天前
已完结
Comment on Frey et al A Real-World Pharmacovigilance Analysis of Lorlatinib-Associated Metabolic Effects Using the FDA Adverse Events Reporting System (FAERS) Database From 2013 to 2024
12天前
已关闭
The association of the Prognostic Nutritional Index (PNI) and Neutrophil-Lymphocyte Ratio (NLR) with cachexia in cancer patients
1个月前
已关闭
Compound Effect of Hypoalbuminemia and Obesity on Complications after Autologous Breast Reconstruction
1个月前
已关闭
Methodological considerations for recombinant human serum albumin clinical translation
2个月前
已完结
Mechanisms of cancer cachexia and targeted therapeutic strategies
2个月前
已完结
Effect of adjuvant EGFR-TKI therapy on the prognosis of pathological stage I invasive lung adenocarcinoma with sensitive EGFR mutations
2个月前
已完结
Current management of uncommon EGFR mutations in non-small cell lung cancer
2个月前
已完结
PT1.07.02 Neoadjuvant Ensartinib for ALK-Positive (ALK+) Non-Small Cell Lung Cancer (NSCLC): A Multicenter, Real-World Study
3个月前
已关闭
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
4个月前
已完结
皖公网安备34019202002308
